Lexeo Therapeutics, Inc. (LXEO) Insider Trading

Name: Lexeo Therapeutics, Inc. (LXEO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 28, 2026): Tamayo Louis Edward (Chief Financial Officer): Grant/Award of 54,750 shares.

Get alerted when insiders trade LXEO

Email address

Loading company data...

Beta

Loading company details...

Beta